| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5950824 | Atherosclerosis | 2011 | 4 Pages |
Abstract
Inhibition of IL-17A signaling does not alter lesion development in Th1-biased C57BL/6 ApoEâ/â and Ldlrâ/â mice with already low levels of IL-17A production. Alteration of lesion development after repeated injections of rat anti-mouse IL-17A antibody in ApoEâ/â mice could not be attributed to blockade of IL-17A signaling.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xiang Cheng, Soraya Taleb, Jun Wang, Ting-Ting Tang, Jian Chen, Xing-Li Gao, Rui Yao, Jiang-Jiao Xie, Xian Yu, Ni Xia, Xin-Xin Yan, Shao-Fang Nie, Meng-Yang Liao, Yan Cheng, Ziad Mallat, Yu-Hua Liao,